Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Saul

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Angewandte Chemie (International Ed. in English)|September 10, 2015
Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate VaccinesGiuseppe Stefanetti, Qi-Ying Hu, Aimee Usera, et al.
Microbiology Spectrum|April 10, 2023
Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coliIrene Beriotto, Christopher Icke, Yanina R Sevastsyanovich, et al.
The American Journal of Tropical Medicine and Hygiene|January 1, 2008
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensityAlassane Dicko, Issaka Sagara, David Diemert, et al.
Vaccine|November 24, 2011
Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction bufferDaming Zhu, Shuhui Huang, Holly McClellan, et al.
Frontiers in Immunology|March 26, 2019
Booster Vaccination With GVGH <i>Shigella sonnei</i> 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical TrialOdile Launay, Augustin G W Ndiaye, Valentino Conti, et al.
Molecular and Biochemical Parasitology|December 17, 2008
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structureChiawei W Tsai, Peter F Duggan, Albert J Jin, et al.
Plos One|October 8, 2011
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adultsPierre van Damme, Froukje Kafeja, Alessandra Anemona, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
Frontiers in Immunology|January 30, 2018
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against <i>Shigella sonnei</i> Administered Intramuscularly to Adults from a Shigellosis-Endemic CountryChristina W Obiero, Augustin G W Ndiaye, Antonella Silvia Sciré, et al.
Vaccine|April 13, 2007
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidatesFeng Qian, Yimin Wu, Olga Muratova, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Angewandte Chemie (International Ed. in English)|September 10, 2015
Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate VaccinesGiuseppe Stefanetti, Qi-Ying Hu, Aimee Usera, et al.
Microbiology Spectrum|April 10, 2023
Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coliIrene Beriotto, Christopher Icke, Yanina R Sevastsyanovich, et al.
The American Journal of Tropical Medicine and Hygiene|January 1, 2008
Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensityAlassane Dicko, Issaka Sagara, David Diemert, et al.
Vaccine|November 24, 2011
Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction bufferDaming Zhu, Shuhui Huang, Holly McClellan, et al.
Frontiers in Immunology|March 26, 2019
Booster Vaccination With GVGH <i>Shigella sonnei</i> 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical TrialOdile Launay, Augustin G W Ndiaye, Valentino Conti, et al.
Molecular and Biochemical Parasitology|December 17, 2008
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structureChiawei W Tsai, Peter F Duggan, Albert J Jin, et al.
Plos One|October 8, 2011
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adultsPierre van Damme, Froukje Kafeja, Alessandra Anemona, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
Frontiers in Immunology|January 30, 2018
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against <i>Shigella sonnei</i> Administered Intramuscularly to Adults from a Shigellosis-Endemic CountryChristina W Obiero, Augustin G W Ndiaye, Antonella Silvia Sciré, et al.
Vaccine|April 13, 2007
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidatesFeng Qian, Yimin Wu, Olga Muratova, et al.
Pageof 13